Yellow Acre Farms CEO, Adan Arriaga, announced on Thursday the submission of "Method for Administering Cannabis-Derived Compounds," to the United States Patent and Trademark Office (USPTO).
The technology, developed by YAF's R&D team, is capable of delivering various cannabis-derived compounds to the body with high bioavailability and extended duration of action via a variable molecule size nanoemulsion.
It brings new possibilities in infusing cannabinoids and other cannabis compounds into longer-lasting liquid, solid, or other consumable forms.
This means that consumers can expect new and better inclusion of cannabis compounds into beverages, syrups, sprays, gummies, sublingual strips, candy, and gel capsules.
"To say that we're super excited here doesn't even begin to cover it," Arriaga said. "We're ready to shake up the industry in ways we haven't seen before. We already know that variable molecule sizes will be the industry standard as more products seek to incorporate CBDa and CBGa with other cannabinoids into their beverages and edibles. We're poised to play a vital role in giving consumers more options to support their health and well-being."
Photo: Courtesy of Esteban Lopez on Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!